Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder

Código QR

Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder

Wen-Jiun Chou,1 Liang-Jen Wang,1 Chien-Ho Lin,2 Sun-Yuan Liang,3 Vincent Chin-Hung Chen,4 Yuh-Ming Hou,5 Rong-Rong Huang,6 Miao-Chun Chou,1 Chi-Yung Shang,7 Chi-Pui Ho,6 Meng-Chuan Lai8 1Department of Child and Adolescent Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chou WJ, Wang LJ, Lin CH, Liang SY, Chen VCH, Hou YM, Huang RR, Chou MC, Shang CY, Ho CP, Lai MC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	ADHD central nervous system stimulant drug adherence family social adjustment Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/9a7c083839914ef18ad7c069ce2d7019
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Decreased Risk of Influenza in Child and Adolescent Patients with Attention-Deficit Hyperactivity Disorder Following Methylphenidate Treatment: A Nationwide Cohort Study in Taiwan
por: Lee H, et al.
Publicado: (2020)

Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder?
por: Chan MH, et al.
Publicado: (2017)

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
por: Jan K Buitelaar, et al.
Publicado: (2009)

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
por: Huss M, et al.
Publicado: (2016)

Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Rajasree Nair, et al.
Publicado: (2009)

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
por: Huss M, et al.
Publicado: (2017)

Potential role of pre- and postnatal testosterone levels in attention-deficit/hyperactivity disorder: is there a sex difference?
por: Wang LJ, et al.
Publicado: (2017)

Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial
por: Martin P. Paulus, et al.
Publicado: (2021)

Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study
por: Valdiz&aacute;n-Us&oacute;n JR, et al.
Publicado: (2013)

The Impact of Methylphenidate on QbTest Performance of Children with ADHD: A Retrospective Clinical Study
por: Knez R, et al.
Publicado: (2021)

A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder
por: Maneeton N, et al.
Publicado: (2014)

Comparison of Persistence and Adherence Between Adults Diagnosed with Attention Deficit/Hyperactivity Disorder in Childhood and Adulthood
por: Lee SM, et al.
Publicado: (2021)

Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder
por: Lamberti M, et al.
Publicado: (2015)

Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment
por: Masi G, et al.
Publicado: (2019)

Six months methylphenidate treatment improves emotion dysregulation in adolescents with attention deficit/hyperactivity disorder: a prospective study
por: Suzer Gamli I, et al.
Publicado: (2018)

The impact of synapsin III gene on the neurometabolite level alterations after single-dose methylphenidate in attention-deficit hyperactivity disorder patients
por: Başay Ö, et al.
Publicado: (2016)

Changes in behavior as side effects in methylphenidate treatment: review of the literature
por: Konrad-Bindl DS, et al.
Publicado: (2016)

Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan
por: Cheng YS, et al.
Publicado: (2017)

Association Between Attention Deficit Hyperactivity Disorder and Risk of Burn Injury: A Propensity-Matched Cohort Study
por: Yeh JY, et al.
Publicado: (2020)

Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
por: Bidzan L, et al.
Publicado: (2020)

Risk factors for the existence of attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders
por: Lamanna AL, et al.
Publicado: (2017)

A Systematic Scoping Review of New Attention Problems Following Traumatic Brain Injury in Children
por: Sonja Stojanovski, et al.
Publicado: (2021)

Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: A placebo-controlled fMRI study
por: Rajamannar Ramasubbu, et al.
Publicado: (2008)

Social function of adult men with attention-deficit/hyperactivity disorder in the context of military service
por: Noh GM, et al.
Publicado: (2018)

Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
por: Treuer T, et al.
Publicado: (2016)

Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment
por: Königs A, et al.
Publicado: (2016)

Reliability and Validity of the Chen ADHD Scale (C-ADHDS)
por: Chen YL, et al.
Publicado: (2021)

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine
por: Imagawa H, et al.
Publicado: (2018)

Optimal management of ADHD in older adults
por: Torgersen T, et al.
Publicado: (2016)

Sleep problems in children with autism spectrum disorder: clinical correlates and the impact of attention deficit hyperactivity disorder
por: Gunes S, et al.
Publicado: (2019)

Attention-deficit hyperactivity disorder in elementary school students in Shantou, China: prevalence, subtypes, and influencing factors
por: Huang Y, et al.
Publicado: (2017)

Association between peripheral manganese levels and attention-deficit/hyperactivity disorder: a preliminary meta-analysis
por: Shih JH, et al.
Publicado: (2018)

Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control
por: Fridman M, et al.
Publicado: (2017)

Attention deficit hyperactivity disorder and disordered eating behaviors: links, risks, and challenges faced
por: Ptacek R, et al.
Publicado: (2016)

Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse
por: Sternat T, et al.
Publicado: (2016)

Attention Deficit Hyperactivity Disorder And Borderline Personality Disorder In Adults: A Review Of Their Links And Risks
por: Weiner L, et al.
Publicado: (2019)

Risk factors for low adherence to methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder
por: Asami Ishizuya, et al.
Publicado: (2021)

Attention–memory training yields behavioral and academic improvements in children diagnosed with attention-deficit hyperactivity disorder comorbid with a learning disorder
por: Farias AC, et al.
Publicado: (2017)

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies
por: Wigal SB, et al.
Publicado: (2020)

Continuous performance task in ADHD: Is reaction time variability a key measure?
por: Levy F, et al.
Publicado: (2018)